| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.31 | 0.1 |